NCT01702961
- Conditions
- Hemic and Lymphatic Diseases, Hodgkin Disease, Hodgkin's Disease, +7 more
- Locations
-
- Texas Children's Hospital Houston, Texas, United States
- The Methodist Hospital Houston, Texas, United States
Clinical trial condition
Lymphoproliferative Disorders
Explore clinical trials studying Lymphoproliferative Disorders. Study availability and eligibility vary by location and protocol.
10,079 public trials
2,046 recruiting studies
Lymphoproliferative Disorders trial results
NCT02095951
- Conditions
- Blood Disorders, Hematologic Diseases, Hemic and Lymphatic Diseases, +9 more
- Locations
-
- Children's Hospital of Michigan Detroit, Michigan, United States
NCT00073749
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
- Locations
-
- UAB CCC Clinical Studies Unit Birmingham, Alabama, United States
- University of Alabama at Birmingham Kirklin Clinic Birmingham, Alabama, United States
- UAB Russell Ambulatory Pharmacy Birmingham, Alabama, United States
- University of Alabama at Birmingham Birmingham, Alabama, United States
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
- Locations
-
- University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
- UCSD Moores Cancer Center La Jolla, California, United States
- Loma Linda University Medical Center Loma Linda, California, United States
- Tower Cancer Research Foundation Los Angeles, California, United States
NCT01165112
- Conditions
- Hemic and Lymphatic Diseases, Hodgkin Disease, Immune System Diseases, +11 more
- Locations
-
- Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States
NCT00923520
- Conditions
- Adenocarcinoma, Breast Cancer, Breast Diseases, +43 more
- Locations
-
- National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States
- Hershey Medical Center Hershey, Pennsylvania, United States
- University of Pittsburgh Pittsburgh, Pennsylvania, United States
NCT01701700
- Conditions
- Eye Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +15 more
- Locations
-
- Manchester Royal Eye Hospital Manchester, United Kingdom
NCT01200758
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
- Locations
-
- Gosford Hospital; Cancer Care Services Gosford, New South Wales, Australia
- Wollongong Hospital; Cancer Services Wollongong, New South Wales, Australia
- Royal Brisbane and Women's Hospital Herston, Queensland, Australia
- Gold Coast Hospital; Haematology Department Southport, Queensland, Australia
Completed
Lenalidomide Following Fludarabine/Rituximab (FR) in Untreated Chronic Lymphocytic Leukemia (CLL)
NCT00860457
- Conditions
- Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +14 more
- Locations
-
- Lombardi Cancer Center at Georgetown University Medical Center Washington D.C., District of Columbia, United States
NCT01470196
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +14 more
- Locations
-
- Dana-Farber Cancer Institute Boston, Massachusetts, United States